Events › Healthcare & MedTech
Healthcare & MedTech
16th edition
15
Exhibitors
850
Attendees
16th World Clinical Biomarkers & Companion Diagnostics Summit is a premier precision medicine forum focusing on biomarker and IVD innovation, uniting global biopharma, diagnostic, lab, and regulatory leaders to advance precision therapies.
Attendees: Senior leaders from biopharma, diagnostics, regulatory bodies, and healthcare organizations.
Exhibitor mix: Categorized into Expertise, Program, Spotlight, Exhibition, and Meeting Partners.
Filter this event to your ICP.
15 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
Venue
The Westin Boston Seaport DistrictHotel venue · 8,361 m² · 27 halls · ~2,000 people
A 16-story hotel connected to the Boston Convention & Exhibition Center, offering over 90,000 sq ft (approx. 8,361 sqm) of flexible, contemporary meeting space across 27+ venues, including the Galleria Exhibit Hall, suitable for large corporate events in the Seaport District.
📍 425 Summer St, Boston, MA 02210, US
Operated by Marriott International
Organizer
Hanson WadePE-backed · London, United Kingdom · Founded 2008
Hanson Wade is a global conference organizer and market intelligence provider focused primarily on the life sciences and biopharma sectors.
Exhibitor list
45 companies are exhibiting at World Clinical Biomarkers & Companion Diagnostics Summit. A sample of 12 is shown below — unlock the full list to see all 45.
33 more exhibitors at World Clinical Biomarkers & Companion Diagnostics Summit.
Unlock the complete exhibitor list — every company, with optional ICP filtering and verified buying-committee contacts per matched account.
Why people attend
To network with over 850 senior precision medicine leaders, explore cutting-edge CDx technologies, and understand evolving global regulatory frameworks for biomarkers.
Exhibitor categories
Speakers
72 speakers at World Clinical Biomarkers & Companion Diagnostics Summit
Head, Precision Medicine · Astellas Pharma
Also speaking at 5th Liquid Biopsy for Precision Oncology Summit East Coast
Marshall Thompson, Ph.D., is the Chief Technology Officer for RCRF, where he applies cutting-edge software practices to genomic-scale biological problems. Marshall has a wealth of experience in the…
Dr. Rowland Illing serves as Chief Medical Officer and Director of Healthcare and Life Sciences for Amazon Web Services (AWS). His work centers on enabling customers to leverage core cloud technology…
Dr. Goldberg is Acting Chief Development Officer at Incendia, responsible for driving the company’s human trials to proof of concept, and for communicating our clinical progress and vision to external…
Priya Chockalingam PhD, is Vice President and Head of Clinical BioAnalytics & Translational Sciences at Beam Therapeutics. She leads cross-functional strategies spanning bioanalytics, biomarkers…
Adriana Racolta, PhD, is a seasoned industry leader with 13 years of experience in diagnostics and regulatory affairs. As Senior Director, Global Regulatory Leader IVD at Bayer…
Sid Mathur is a diagnostics regulatory leader with 20 years of experience, including 15 years in companion diagnostics. He leads Merck’s global Diagnostics Regulatory team…
Etai Jacob, PhD, leads Applied Data Science & AI for Oncology R&D at AstraZeneca, where he scaled global teams of data scientists, computational biologists, and AI researchers to operationalize AI…
Amy Kao is the Global Head of the Research Unit Neuroscience & Immunology and Billerica R&D Campus Head at EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany.
+ 56 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions